The number of women who mention, almost as an aside, that their asthma 'just got weird' in their mid-forties is striking. They've already seen their GP, adjusted their inhalers, had allergy panels redone — and nobody mentioned hormones once. If that sounds familiar, this page is the conversation that should have happened at that appointment.
Learn more about Rose →Estrogen receptors are present throughout the respiratory tract, including bronchial smooth muscle and the epithelial lining of the airways. At stable premenopausal levels, estrogen helps suppress the production of pro-inflammatory cytokines — the chemical messengers that trigger airway swelling and mucus overproduction. As estrogen fluctuates and declines in perimenopause, that buffering effect becomes unreliable, leaving the airways more reactive to the same triggers that never used to cause problems.
Progesterone is a known respiratory stimulant that increases the sensitivity of the brain's breathing centers and helps maintain airway tone. During the luteal phase of a regular cycle, higher progesterone levels have been shown to improve lung function measures in some women with asthma. In perimenopause, progesterone levels drop earlier and more steeply than estrogen, meaning this protective respiratory effect can disappear years before the final menstrual period.
Mast cells are the immune cells that release histamine and other chemicals during an asthma attack or allergic response, and their activity is directly modulated by estrogen and progesterone. Estrogen at high levels can actually prime mast cells to be more reactive, while progesterone tends to stabilize them — meaning the erratic hormonal swings of perimenopause can push mast cell behavior in unpredictable directions. Some women find their asthma and allergy symptoms intensify in the weeks around ovulation or just before a period, which reflects exactly this mast cell volatility.
The hormonal shift of perimenopause promotes central adiposity — fat redistribution toward the abdomen and trunk — even in women whose overall weight changes very little. Abdominal fat physically reduces the space available for the diaphragm to move, increases the work of breathing, and raises the risk of gastroesophageal reflux, which is itself a known asthma trigger. Women who notice their breathing feels more labored during mild exertion in perimenopause may be experiencing this mechanical effect alongside any inflammatory changes.
Perimenopause-related sleep disturbances — from night sweats, insomnia, or both — mean that many women are in a state of chronic partial sleep deprivation for months or years. Sleep is when the immune system performs much of its regulatory housekeeping, and poor sleep is independently associated with increased airway inflammation and reduced asthma control the following day. Research in people with asthma consistently shows that nocturnal symptoms and daytime control worsen when sleep quality drops, creating a compounding cycle that's hard to separate from the underlying hormonal picture.
Perimenopause is associated with heightened stress reactivity partly because fluctuating estrogen destabilizes the HPA axis — the body's core stress-response system. Chronic psychological stress elevates cortisol, and while short-term cortisol spikes are anti-inflammatory, sustained high cortisol paradoxically promotes immune dysregulation and can worsen airway hyperreactivity over time. Women navigating the anxiety, mood shifts, and life pressures that often coincide with midlife may find that their stress load alone is contributing meaningfully to poorer asthma control.
Before puberty, asthma is more prevalent in boys; after puberty, the pattern reverses, and women overtake men in both incidence and severity — a difference researchers attribute largely to sex hormones. Epidemiological data show a notable spike in new asthma diagnoses in women in their forties and fifties, coinciding with the perimenopausal window. Many of these women have no prior asthma history, which makes the hormonal connection even more striking and helps explain why the diagnosis is sometimes delayed or initially attributed to anxiety or deconditioning.
GERD rates rise in perimenopause due to hormonal effects on the lower esophageal sphincter, changes in abdominal pressure from weight redistribution, and increased anxiety. Acid reflux triggers asthma through two mechanisms: direct micro-aspiration of acid into the airways, and a vagal nerve reflex that causes bronchospasm even without any acid reaching the lungs. Women who notice their asthma is particularly bad at night or after meals, without obvious allergic triggers, should consider whether reflux is playing a role that's being missed.
Some studies have found that women on combined estrogen-progesterone hormone therapy have more asthma symptoms than non-users, while other research suggests estrogen-only therapy in post-menopausal women may reduce airway hyperreactivity. The picture is complicated by the fact that different progestogens behave differently in airways, and individual women's responses vary considerably. This is an area where a direct, honest conversation with both a respiratory specialist and a menopause-informed clinician is genuinely valuable — the answer isn't simple, but it's also not a reason to avoid the conversation.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.